XML 31 R22.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Accounting Policies [Abstract]          
Research and Development Expense $ 73,834 $ 79,788 $ 105,934 $ 141,207  
Deferred Revenue 140,000   $ 140,000   $ 140,000
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount     670,982,011 673,692,795  
Depreciation $ 5,465 $ 5,465 $ 10,930 $ 10,930